Age-related genetic abnormalities: The Achilles' heel for customizing therapy in elderly lung cancer patients

Rafael Rosell, Mariacarmela Santarpia, Teresa Moran, Maria Fernanda Salazar, Diego Lucas Kaen, Jose Luis Ramirez

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aging and cancer are closely related, and DNA repair systems, mainly involving the nucleotide excision repair pathway, have an important caretaker function in both processes. More than half of non-small cell lung cancer patients are elderly, and the expression of some genes involved in the mitotic checkpoint, such as BubR1, declines with aging. Cisplatin-based chemotherapy is the standard treatment for advanced non-small cell lung cancer; if performance status is good, both elderly and younger patients can tolerate this treatment equally well. Customized cisplatin treatment, based on reduction of the nucleotide excision repair pathway function, could be an attractive approach, and the assessment of mitotic checkpoint genes can be used for selecting docetaxel treatment. Epidermal growth factor receptor (EGFR) mutations are particularly frequent in elderly lung cancer patients who are never-smokers and constitute an attractive target for treatment with EGFR tyrosine kinase inhibitors.

Original languageEnglish
Pages (from-to)59-72
Number of pages14
JournalPersonalized Medicine
Volume4
Issue number1
DOIs
Publication statusPublished - Feb 2007

Fingerprint

Lung Neoplasms
DNA Repair
M Phase Cell Cycle Checkpoints
docetaxel
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Cisplatin
Therapeutics
Protein-Tyrosine Kinases
Gene Expression
Drug Therapy
Mutation
Genes
Neoplasms

Keywords

  • CHFR
  • EGFR mutations
  • Elderly
  • Epidermal growth factor receptor
  • ERCC1
  • Mitotic checkpoint genes
  • Non-small cell lung cancer

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Medicine(all)

Cite this

Age-related genetic abnormalities : The Achilles' heel for customizing therapy in elderly lung cancer patients. / Rosell, Rafael; Santarpia, Mariacarmela; Moran, Teresa; Salazar, Maria Fernanda; Kaen, Diego Lucas; Ramirez, Jose Luis.

In: Personalized Medicine, Vol. 4, No. 1, 02.2007, p. 59-72.

Research output: Contribution to journalArticle

Rosell, Rafael ; Santarpia, Mariacarmela ; Moran, Teresa ; Salazar, Maria Fernanda ; Kaen, Diego Lucas ; Ramirez, Jose Luis. / Age-related genetic abnormalities : The Achilles' heel for customizing therapy in elderly lung cancer patients. In: Personalized Medicine. 2007 ; Vol. 4, No. 1. pp. 59-72.
@article{21783fc3d5164397b3c53053a216efa6,
title = "Age-related genetic abnormalities: The Achilles' heel for customizing therapy in elderly lung cancer patients",
abstract = "Aging and cancer are closely related, and DNA repair systems, mainly involving the nucleotide excision repair pathway, have an important caretaker function in both processes. More than half of non-small cell lung cancer patients are elderly, and the expression of some genes involved in the mitotic checkpoint, such as BubR1, declines with aging. Cisplatin-based chemotherapy is the standard treatment for advanced non-small cell lung cancer; if performance status is good, both elderly and younger patients can tolerate this treatment equally well. Customized cisplatin treatment, based on reduction of the nucleotide excision repair pathway function, could be an attractive approach, and the assessment of mitotic checkpoint genes can be used for selecting docetaxel treatment. Epidermal growth factor receptor (EGFR) mutations are particularly frequent in elderly lung cancer patients who are never-smokers and constitute an attractive target for treatment with EGFR tyrosine kinase inhibitors.",
keywords = "CHFR, EGFR mutations, Elderly, Epidermal growth factor receptor, ERCC1, Mitotic checkpoint genes, Non-small cell lung cancer",
author = "Rafael Rosell and Mariacarmela Santarpia and Teresa Moran and Salazar, {Maria Fernanda} and Kaen, {Diego Lucas} and Ramirez, {Jose Luis}",
year = "2007",
month = "2",
doi = "10.2217/17410541.4.1.59",
language = "English",
volume = "4",
pages = "59--72",
journal = "Personalized Medicine",
issn = "1741-0541",
publisher = "Future Medicine Ltd.",
number = "1",

}

TY - JOUR

T1 - Age-related genetic abnormalities

T2 - The Achilles' heel for customizing therapy in elderly lung cancer patients

AU - Rosell, Rafael

AU - Santarpia, Mariacarmela

AU - Moran, Teresa

AU - Salazar, Maria Fernanda

AU - Kaen, Diego Lucas

AU - Ramirez, Jose Luis

PY - 2007/2

Y1 - 2007/2

N2 - Aging and cancer are closely related, and DNA repair systems, mainly involving the nucleotide excision repair pathway, have an important caretaker function in both processes. More than half of non-small cell lung cancer patients are elderly, and the expression of some genes involved in the mitotic checkpoint, such as BubR1, declines with aging. Cisplatin-based chemotherapy is the standard treatment for advanced non-small cell lung cancer; if performance status is good, both elderly and younger patients can tolerate this treatment equally well. Customized cisplatin treatment, based on reduction of the nucleotide excision repair pathway function, could be an attractive approach, and the assessment of mitotic checkpoint genes can be used for selecting docetaxel treatment. Epidermal growth factor receptor (EGFR) mutations are particularly frequent in elderly lung cancer patients who are never-smokers and constitute an attractive target for treatment with EGFR tyrosine kinase inhibitors.

AB - Aging and cancer are closely related, and DNA repair systems, mainly involving the nucleotide excision repair pathway, have an important caretaker function in both processes. More than half of non-small cell lung cancer patients are elderly, and the expression of some genes involved in the mitotic checkpoint, such as BubR1, declines with aging. Cisplatin-based chemotherapy is the standard treatment for advanced non-small cell lung cancer; if performance status is good, both elderly and younger patients can tolerate this treatment equally well. Customized cisplatin treatment, based on reduction of the nucleotide excision repair pathway function, could be an attractive approach, and the assessment of mitotic checkpoint genes can be used for selecting docetaxel treatment. Epidermal growth factor receptor (EGFR) mutations are particularly frequent in elderly lung cancer patients who are never-smokers and constitute an attractive target for treatment with EGFR tyrosine kinase inhibitors.

KW - CHFR

KW - EGFR mutations

KW - Elderly

KW - Epidermal growth factor receptor

KW - ERCC1

KW - Mitotic checkpoint genes

KW - Non-small cell lung cancer

UR - http://www.scopus.com/inward/record.url?scp=33847064257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847064257&partnerID=8YFLogxK

U2 - 10.2217/17410541.4.1.59

DO - 10.2217/17410541.4.1.59

M3 - Article

AN - SCOPUS:33847064257

VL - 4

SP - 59

EP - 72

JO - Personalized Medicine

JF - Personalized Medicine

SN - 1741-0541

IS - 1

ER -